Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

(2016) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

(2016)   DIABETOLOGIA

Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes

(2016) Elena Toschi et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

(2016) Anne L. Peters et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

(2016) Jan Bolinder et al.   LANCET

Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes

(2016) Rozalina G. McCoy et al.   JAMA Internal Medicine

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions

(2015) Frank Pistrosch et al.   ACTA DIABETOLOGICA

Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk

(2014) Elaine Chow et al.   DIABETES

Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry

(2014) Jenise C. Wong et al.   DIABETES CARE

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) E. R. Seaquist et al.   DIABETES CARE

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial

(2013) et al.   EUROPEAN HEART JOURNAL

Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

(2011) R. A. Vigersky et al.   DIABETES CARE

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE